v3.25.1
Stock-Based Compensation
3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Stock-based compensation
8.
Stock-Based Compensation

Stock Option Valuation

For stock options requiring an assessment of value during the three months ended March 31, 2025 and 2024, the fair value of each stock option award was estimated using the Black-Scholes option-pricing model utilizing the following assumptions:

 

 

 

March 31, 2025

Risk-free interest rate

 

4.05% - 4.46%

Expected dividend yield

 

0%

Expected volatility

 

86.46% - 87.69%

Expected life

 

5.50 to 6.25 years

 

 

 

 

 

March 31, 2024

Risk-free interest rate

 

3.83% - 4.28%

Expected dividend yield

 

0%

Expected volatility

 

66.27% - 109.86%

Expected life

 

5.50 to 8.91 years

 

A summary of stock option activity for the three months ended March 31, 2025 is as follows:

 

 

 

Number of
Shares

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Life
(in Years)

 

Stock options outstanding at December 31, 2024

 

 

10,471,724

 

 

$

5.61

 

 

 

7.27

 

Granted

 

 

1,889,300

 

 

 

0.99

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

Cancelled

 

 

(22,563

)

 

 

3.42

 

 

 

 

Stock options outstanding at March 31, 2025

 

 

12,338,461

 

 

 

4.91

 

 

 

7.48

 

Stock options exercisable at March 31, 2025

 

 

5,982,995

 

 

$

8.41

 

 

 

5.63

 

 

The aggregate intrinsic value of exercisable but unexercised in-the-money stock options at March 31, 2025 was less than $0.1 million based on a weighted average exercise price of $8.41 per share. The aggregate intrinsic value of options is calculated as the difference of the market close price of $0.91 on March 31, 2025, and the weighted average exercise price of $8.41, with a weighted average remaining contractual term of 5.63 years.

 

Stock-based Compensation

Stock-based compensation for the three months ended March 31, 2025 and 2024 was included in the Company’s condensed consolidated statements of operations and comprehensive loss as follows:

 

 

 

Three Months Ended
March 31,

 

(in thousands)

 

2025

 

 

2024

 

General and administrative

 

$

695

 

 

$

956

 

Research and development

 

 

643

 

 

 

990

 

Total stock-based compensation

 

$

1,338

 

 

$

1,946

 

 

As of March 31, 2025, total unrecognized stock-based compensation expense was $6.0 million, which is expected to be recognized as an operating expense in the Company’s condensed consolidated statements of operations and comprehensive loss over the weighted average remaining period of 2.15 years.